Why AMC Entertainment Holdings Shares Are Trading Lower By 25%; Here Are 20 Stocks Moving Premarket

Gainers

• AMC Entertainment Hldg Pref Equity Units APE gained 28.4% to $1.90 in pre-market trading. AMC Entertainment Holdings stated it agreed to settle litigation and move forward with converting its preferred stock into common shares.
• Butterfly Network, Inc. BFLY jumped 26.2% to $2.36 in pre-market trading after the company received 510(k) clearance for AI-Enable Auto B-Line Counter.
• Addex Therapeutics Ltd ADXN gained 15.7% to $1.15 in pre-market trading. Addex published dipraglurant data showing in vivo efficacy on motor and non-motor symptoms of Parkinson's disease.
• Meta Materials Inc. MMAT shares climbed 13.2% to $0.5565 in pre-market trading after jumping 20% on Monday. Meta Materials recently signed a joint development agreement for NPORE battery separator materials with a confidential global Top 10 battery OEM.
• Clever Leaves Holdings Inc CLVR climbed 12.3% to $0.40 in pre-market trading. The company recently posted upbeat Q4 results.
• Steakholder Foods Ltd STKH gained 11% to $0.76 in pre-market trading after declining over 3% on Monday.
• Lipocine Inc LPCN gained 10.4% to $0.35 in pre-market trading. Lipocine said first participant has been dosed in pilot clinical bridge study of LPCN 1154 and approved injectable Brexanolone.
• Wearable Devices Ltd WLDS surged 9.6% to $0.51 in pre-market trading after dropping more than 10% on Monday. Wearable Devices recently reported 2022 financial results.
• Comera Life Sciences Holdings Inc CMRA climbed 9% to $0.97 in pre-market trading. Comera Life Sciences announced notice of allowance of US patent application for expansion of core viscosity reduction claims for excipients in SQore platform.
• PLx Pharma Inc PLXP gained 8.8% to $0.13 in pre-market trading after dropping around 4% on Monday.

Losers

• Oncternal Therapeutics, Inc. ONCT fell 57.1% to $0.3390 in pre-market trading after the company disclosed strategic reprioritization and capital preservation. The Zilovertamab Phase 3 study ZILO-301 and Phase 1/2 study CIRM-0001 will be closed based on dynamically changing therapeutic landscape.
• AMC Entertainment Holdings, Inc. AMC fell 25% to $3.83 in pre-market trading. AMC Entertainment agreed to settle litigation and move forward with converting its preferred stock into common shares.
• Remark Holdings Inc MARK shares dropped 16.2% to $1.24 in pre-market trading after the company filed non-timely 10-K with the SEC. The company said it expects revenue for the year ended Dec. 31, 2022 to be significantly less year over year.
• Codiak BioSciences, Inc. CDAK fell 14.2% to $0.1110 in pre-market trading after dipping over 25% on Monday. Codiak BioSciences recently voluntarily filed for protection under Chapter 11 bankruptcy.
• ReTo Eco-Solutions Inc RETO fell 11% to $0.32 in pre-market trading after dropping around 8% on Monday. ReTo Eco-Solutions subsidiary recently received overseas order for fully automated block production lines.
• Harbor Custom Development Inc HCDI fell 8.7% to $5.47 in pre-market after jumping 38% on Monday. Harbor Custom Development recently reported worse-than-expected Q4 sales results.
• T Stamp Inc IDAI fell 8.3% to $2.75 in pre-market trading. T Stamp filed for mixed-securities shelf offering of up to $50 million.
• Terran Orbital Corporation LLAP shares fell 7.5% to $1.72 in pre-market trading.
• Kazia Therapeutics Ltd KZIA fell 6.8% to $0.96 in pre-market trading.
• Alaunos Therapeutics Inc TCRT shares fell 5.7% to $0.59 in pre-market trading.

Now Read This: Top 4 Materials Stocks That Set To Fly In April